Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2011

01.10.2011 | AMERICAN SOCIETY OF BREAST SURGEONS

Definitive Diagnosis for High-Risk Breast Lesions Without Open Surgical Excision: The Intact Percutaneous Excision Trial (IPET)

verfasst von: Pat W. Whitworth, MD, Jean F. Simpson, MD, William R. Poller, MD, Steven M. Schonholz, MD, John F. Turner, MD, Rogsbert F. Phillips, MD, Joel M. Johnson, MD, F. David McEachin, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Open surgical excision (OSE) is generally recommended when image-guided core-needle breast biopsy demonstrates a high-risk lesion (HRL). We evaluated intact percutaneous excision (IPEX) with standard radiologic and histologic criteria for definitive diagnosis of HRL, particularly atypical ductal hyperplasia (ADH). The primary aim is to confirm criteria associated with <2% risk for upgrade to carcinoma, equivalent to risk associated with Breast Imaging Reporting and Data System (BI-RADS) 3 lesions, for which imaging surveillance is considered sufficient.

Methods

In a prospective trial, 1,170 patients recommended for breast biopsy at 25 institutions received IPEX with a vacuum- and radiofrequency-assisted device. ADH patients in whom the imaged lesion had been removed and the lesion adequately centered for definitive characterization were designated as the potential surgical avoidance population (PSAP) before OSE. Subsequent OSE specimen pathology was compared with IPEX findings.

Results

In 1,170 patients, 191 carcinomas and 83 (7%) HRL, including 32 ADH (3%), were diagnosed via IPEX. None of the 51 non-ADH HRL were upgraded to carcinoma on OSE (n = 24) or, if OSE was declined, on radiologic follow-up (n = 27). No ADH lesions meeting PSAP criteria (n = 10) were upgraded to carcinoma on OSE; 3 (14%) of 22 non-PSAP ADH lesions were upgraded to carcinoma on OSE. In summary, no upgrades to carcinoma were made in patients with non-ADH lesions who underwent IPEX or in ADH patients who had IPEX, met histologic and radiologic criteria, and underwent OSE or follow-up.

Conclusion

IPEX combined with straightforward histologic and radiologic criteria and imaging surveillance constitutes acceptable management of image-detected HRL, including ADH.
Literatur
1.
Zurück zum Zitat Silverstein MJ, Recht A, Lagios MD, et al. Special report: consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209:504–20.PubMedCrossRef Silverstein MJ, Recht A, Lagios MD, et al. Special report: consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209:504–20.PubMedCrossRef
2.
Zurück zum Zitat Forgeard C, Benchaib M, Guerin N, et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg. 2008;196:339–45.PubMedCrossRef Forgeard C, Benchaib M, Guerin N, et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg. 2008;196:339–45.PubMedCrossRef
3.
Zurück zum Zitat Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, et al. Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg. 2008;195:358–61; discussion 361–2.PubMedCrossRef Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, et al. Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg. 2008;195:358–61; discussion 361–2.PubMedCrossRef
4.
Zurück zum Zitat Hoang JK, Hill P, Cawson JN. Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy? Breast. 2008;17:282–8.PubMedCrossRef Hoang JK, Hill P, Cawson JN. Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy? Breast. 2008;17:282–8.PubMedCrossRef
5.
Zurück zum Zitat Allison KH, Eby PR, Kohr J, DeMartini WB, Lehman CD. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011;42:41–50.PubMedCrossRef Allison KH, Eby PR, Kohr J, DeMartini WB, Lehman CD. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011;42:41–50.PubMedCrossRef
6.
Zurück zum Zitat Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, et al. Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology. 2010;255:723–30. Epub Feb. 19, 2010.PubMedCrossRef Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, et al. Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology. 2010;255:723–30. Epub Feb. 19, 2010.PubMedCrossRef
7.
Zurück zum Zitat Albarracin CT, Nguyen CV, Whitman GJ, Weiang W, Sneige N. Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy. Radiology. 2010;257:893–4; author reply 984.PubMedCrossRef Albarracin CT, Nguyen CV, Whitman GJ, Weiang W, Sneige N. Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy. Radiology. 2010;257:893–4; author reply 984.PubMedCrossRef
8.
Zurück zum Zitat Nguyen CV, Albarracin CT, Whitman GJ, Lopez A, Sneige N. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol. 2011;18:752–61.PubMedCrossRef Nguyen CV, Albarracin CT, Whitman GJ, Lopez A, Sneige N. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol. 2011;18:752–61.PubMedCrossRef
9.
Zurück zum Zitat Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol. 2000;175:1341–6.PubMed Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol. 2000;175:1341–6.PubMed
10.
Zurück zum Zitat D’Orsi CJ, Mendelson EB, Ikeda DM, et al: Breast Imaging Reporting and Data System: ACR BI-RADS—breast imaging atlas. Reston, VA: American College of Radiology; 2003. D’Orsi CJ, Mendelson EB, Ikeda DM, et al: Breast Imaging Reporting and Data System: ACR BI-RADS—breast imaging atlas. Reston, VA: American College of Radiology; 2003.
11.
Zurück zum Zitat Silverstein MJ, Lagios MD, Recht A, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.PubMedCrossRef Silverstein MJ, Lagios MD, Recht A, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.PubMedCrossRef
12.
Zurück zum Zitat Rogers LW. Breast biopsy: a pathologist’s perspective on biopsy acquisition techniques and devices with mammographic–pathologic correlation. Semin Breast Dis. 2005;8:127–37.CrossRef Rogers LW. Breast biopsy: a pathologist’s perspective on biopsy acquisition techniques and devices with mammographic–pathologic correlation. Semin Breast Dis. 2005;8:127–37.CrossRef
13.
Zurück zum Zitat Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer. 2006;107:945–9.PubMedCrossRef Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer. 2006;107:945–9.PubMedCrossRef
14.
Zurück zum Zitat Killebrew LK, Oneson RH. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience. Breast J. 2006;12:302–8.PubMedCrossRef Killebrew LK, Oneson RH. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience. Breast J. 2006;12:302–8.PubMedCrossRef
15.
Zurück zum Zitat Smart CE, Furnival CM, Lakhani SR. High-risk lesions: ALH/LCIS/ADH. In: Kuerer HM, editor. Kuerer’s breast surgical oncology. New York, NY: McGraw-Hill; 2010. Chap 17, pp 179–87. Smart CE, Furnival CM, Lakhani SR. High-risk lesions: ALH/LCIS/ADH. In: Kuerer HM, editor. Kuerer’s breast surgical oncology. New York, NY: McGraw-Hill; 2010. Chap 17, pp 179–87.
16.
Zurück zum Zitat Bruening W, Schoelles K, Treadwell J, Launders J, Fontanarosa J, Tipton K. Comparative effectiveness of core-needle and open surgical biopsy for the diagnosis of breast lesions. Comparative Effectiveness Review No. 19. Prepared by ECRI Institute Evidence-based Practice Center under Contract No. 290-02-0019. Rockville, MD: Agency for Healthcare Research and Quality. December 2009. Bruening W, Schoelles K, Treadwell J, Launders J, Fontanarosa J, Tipton K. Comparative effectiveness of core-needle and open surgical biopsy for the diagnosis of breast lesions. Comparative Effectiveness Review No. 19. Prepared by ECRI Institute Evidence-based Practice Center under Contract No. 290-02-0019. Rockville, MD: Agency for Healthcare Research and Quality. December 2009.
17.
Zurück zum Zitat Grady I, Gorsuch H, Wilburn-Bailey S. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg. 2005;201:14–7.PubMedCrossRef Grady I, Gorsuch H, Wilburn-Bailey S. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg. 2005;201:14–7.PubMedCrossRef
18.
Zurück zum Zitat Koskela AK, Sudan M, Berg MH, Kärjä VJ, Mustonen PK, Kataja V, et al. Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis? Radiology. 2005;236:801–9.PubMedCrossRef Koskela AK, Sudan M, Berg MH, Kärjä VJ, Mustonen PK, Kataja V, et al. Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis? Radiology. 2005;236:801–9.PubMedCrossRef
19.
Zurück zum Zitat Walker TM. Impalpable breast lesions: stereotactic core biopsy with an “add-on” unit. Breast. 1997;6:126–31.CrossRef Walker TM. Impalpable breast lesions: stereotactic core biopsy with an “add-on” unit. Breast. 1997;6:126–31.CrossRef
20.
Zurück zum Zitat Boarki K, Labib M. The role of US guided handheld vacuum assisted breast core biopsy (VACB) in the surgical management of breast nodules: preliminary report of KCCC experience. Gulf J Oncol. 2008 Jul;(4):39–44. Boarki K, Labib M. The role of US guided handheld vacuum assisted breast core biopsy (VACB) in the surgical management of breast nodules: preliminary report of KCCC experience. Gulf J Oncol. 2008 Jul;(4):39–44.
21.
Zurück zum Zitat March DE, Coughlin BF, Barham RB, et al. Breast masses: removal of all US evidence during biopsy by using a handheld vacuum-assisted device—initial experience. Radiology. 2003;227:549–55. Epub 2003 Apr 3.PubMedCrossRef March DE, Coughlin BF, Barham RB, et al. Breast masses: removal of all US evidence during biopsy by using a handheld vacuum-assisted device—initial experience. Radiology. 2003;227:549–55. Epub 2003 Apr 3.PubMedCrossRef
22.
Zurück zum Zitat Parker SH, Klaus AJ, McWey PJ, et al. Sonographically guided directional vacuum-assisted breast biopsy using a handheld device. AJR Am J Roentgenol. 2001;177:405–8.PubMed Parker SH, Klaus AJ, McWey PJ, et al. Sonographically guided directional vacuum-assisted breast biopsy using a handheld device. AJR Am J Roentgenol. 2001;177:405–8.PubMed
23.
Zurück zum Zitat Chen SC, Yang HR, Hwang TL, Chen MF, Cheung YC, Hsueh S. Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Ann Surg. 2003;238:738–42.PubMedCrossRef Chen SC, Yang HR, Hwang TL, Chen MF, Cheung YC, Hsueh S. Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Ann Surg. 2003;238:738–42.PubMedCrossRef
24.
Zurück zum Zitat Johnson AT, Henry-Tillman RS, Smith LF, et al. Percutaneous excisional breast biopsy. Am J Surg. 2002;184:550–4; discussion 554.PubMedCrossRef Johnson AT, Henry-Tillman RS, Smith LF, et al. Percutaneous excisional breast biopsy. Am J Surg. 2002;184:550–4; discussion 554.PubMedCrossRef
25.
Zurück zum Zitat Vargas HI, Vargas MP, Gonzalez K, Burla M, Khalkhali I. Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization. Breast J. 2006;12(suppl 2):S218–22.PubMedCrossRef Vargas HI, Vargas MP, Gonzalez K, Burla M, Khalkhali I. Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization. Breast J. 2006;12(suppl 2):S218–22.PubMedCrossRef
26.
Zurück zum Zitat Fine RE, Boyd BA, Whitworth PW, Kim JA, Harness JK, Burak WE. Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance. Am J Surg. 2002;184:332–6.PubMedCrossRef Fine RE, Boyd BA, Whitworth PW, Kim JA, Harness JK, Burak WE. Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance. Am J Surg. 2002;184:332–6.PubMedCrossRef
27.
Zurück zum Zitat Alonso-Bartolomé F, Vega-Bolívar A, Torres-Tabanera M, et al. Sonographically guided 11-G directional vacuum-assisted breast biopsy as an alternative to surgical excision: utility and cost study in probably benign lesions. Acta Radiol. 2004;45:390–6.PubMedCrossRef Alonso-Bartolomé F, Vega-Bolívar A, Torres-Tabanera M, et al. Sonographically guided 11-G directional vacuum-assisted breast biopsy as an alternative to surgical excision: utility and cost study in probably benign lesions. Acta Radiol. 2004;45:390–6.PubMedCrossRef
28.
Zurück zum Zitat Allen SD, Nerurkar A, Della Rovere GU. The breast lesion excision system (BLES): a novel technique in the diagnostic and therapeutic management of small indeterminate breast lesions? Eur Radiol. 2011;Jan 15. [Epub ahead of print]. Allen SD, Nerurkar A, Della Rovere GU. The breast lesion excision system (BLES): a novel technique in the diagnostic and therapeutic management of small indeterminate breast lesions? Eur Radiol. 2011;Jan 15. [Epub ahead of print].
Metadaten
Titel
Definitive Diagnosis for High-Risk Breast Lesions Without Open Surgical Excision: The Intact Percutaneous Excision Trial (IPET)
verfasst von
Pat W. Whitworth, MD
Jean F. Simpson, MD
William R. Poller, MD
Steven M. Schonholz, MD
John F. Turner, MD
Rogsbert F. Phillips, MD
Joel M. Johnson, MD
F. David McEachin, MD
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1911-0

Weitere Artikel der Ausgabe 11/2011

Annals of Surgical Oncology 11/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.